Position in LLY
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$814,698,234
+$10,740,798 QoQ
Shares Held
885,763
+18.4% QoQ
Ownership
0.094%
of shares outstanding
% of Portfolio
2.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bank Julius Baer & Co. Ltd, Zurich holds $2,442,122,150 across 12 Drug Manufacturers - General names. LLY ranks #1 (33.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
885,763 | $814,698,234 | |
| 2 | JNJ |
Johnson & Johnson
|
2,765,022 | $675,881,977 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,700,222 | $445,099,704 | |
| 4 | AZN |
Astrazeneca PLC
|
1,866,132 | $368,038,553 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,280,971 | $77,690,891 | |
| 6 | ABBV |
AbbVie Inc.
|
124,985 | $27,182,987 | |
| 7 | PFE |
Pfizer Inc
|
913,851 | $25,660,936 | |
| 8 | AMGN |
Amgen Inc
|
16,296 | $5,733,747 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $814,698,234 | 885,763 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $803,957,436 | 748,090 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $604,971,255 | 792,885 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $625,122,256 | 801,922 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $664,657,679 | 804,758 | Shares | Sole | 2025-09-17 | |
| 2024-12-31 | $575,264,292 | 745,161 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $568,767,278 | 641,993 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $621,269,039 | 686,197 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $560,386,370 | 720,328 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,698,333 | 11,491 | Shares | Sole | 2024-05-16 | |
| 2023-09-30 | $265,591,448 | 494,464 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $9,736,024 | 20,760 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $1,227,039 | 3,573 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,641,889 | 4,488 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,667,839 | 5,158 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $774,261 | 2,388 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $896,051 | 3,129 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $55,244 | 200 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $46,210 | 200 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $45,904 | 200 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $37,364 | 200 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $191,971 | 1,137 | Shares | Sole | 2021-02-24 | |
| 2020-09-30 | $483,729 | 3,268 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $381,882 | 2,326 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $2,006,307 | 14,463 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||